Çѱ¹Á¦¾àÇùȸ(ȸÀå ÀÌ°æÈ£)´Â 10ÀÏ ¼¿ï ½ºÅÄÆ÷µå È£ÅÚ¿¡¼ ‘ÇÑ-Áß ¾çÀÚÇù·ÂÀÇ »õ·Î¿î ½Ã´ë’¸¦ ÁÖÁ¦·Î Á¦2Â÷ ÇÑ-Áß Á¦¾àÇùȸ °øµ¿¼¼¹Ì³ª¸¦ °³ÃÖÇÑ´Ù.
À̹ø ÇÑ·Áß Á¦¾àÇùȸ °øµ¿¼¼¹Ì³ª´Â ´Ü¼ø ±³·ù°¡ ¾Æ´Ñ ±Þº¯ÇÏ´Â ±Û·Î¹ú Á¦¾à½ÃÀå ȯ°æÇÏ¿¡¼ ¾ç±¹ÀÌ Àηù°Ç°ÁõÁøÀ» µµ¸ðÇÏ°í Áö¼Ó °¡´ÉÇÑ Á¦¾à»ê¾÷ ¹ßÀüÀ» À§ÇÑ °í¹Î°ú ³íÀǸ¦ ÇÔ²²ÇÏ´Â ÀåÀÌ µÉ °ÍÀÌ´Ù.
¼¼¹Ì³ª´Â 10ÀÏ ¿ÀÀü¿¡ °³È¸½Ä°ú ÇÔ²² ÇÑ-Áß ¾ç±¹ÀÇ ÀÎÇã°¡ ÁÖ¿ä»çÇ׿¡ ´ëÇÏ¿© Çѱ¹Ãø¿¡¼´Â À¯ÇѾçÇà °³¹ß½Ç »çö±â »ó¹«°¡, Áß±¹Ãø¿¡¼´Â Ms. Zhao Lili, Àü Deputy Director State Food and Drug Administration(SFDA)°¡ ¹ßÇ¥¸¦ ÇÑ´Ù.
ÀÌ¾î¼ ¿ÀÈļ½¼Ç¿¡´Â Çѱ¹ÀÇ ¾à°¡Á¦µµ¿¡ ´ëÇÏ¿© Áß¿ÜÁ¦¾à Á¤Áø¿ë ºÎÀåÀÌ, Áß±¹ÀÇ À¯Åë, ¸¶ÄÉÆÿ¡ ´ëÇÏ¿© Mr. Lu Jun, Vice-President Sinopharm Group Co. LtdÀÌ, Çѱ¹ÀÇ ¹ÙÀÌ¿À¿¡ ´ëÇÏ¿© ÀϾç¾àÇ° ¹é½Å»ý»êº»ºÎ ¾Èâ³² »ó¹«°¡, Áß±¹ÀÇ ¹ÙÀÌ¿À¿¡ ´ëÇÏ¿© Mr. Guo Shenggi, Researcher Shanghai Instiute of Biological°¡, Áß±¹ÀÇ Á¦¾àÅõÀÚ ¹× °³¹ß¿¡ ´ëÇÏ¿© Mr. Cai Tian, Tianjin Boxin Investment Management CenterÀÌ, ¿À¼Û»ý¸í°úÇдÜÁö ¼Ò°³¿¡ ´ëÇØ ¿À¼Û÷´ÜÀÇ·á»ê¾÷ÁøÈïÀç´Ü ±èÀçȯ ÀÓ»ó½ÃÇè½Å¾à»ý»ê¼¾ÅÍÀåÀÌ ¹ßÇ¥¸¦ ÇÑ´Ù.
ÇÑÆí ÇÑ-Áß Á¦¾àÇùȸ´Â Áö³ 2010³â Çѱ¹Á¦¾àÇùȸ¿Í Áß±¹Á¦¾àÇùȸ°¡ ¾ç±¹ÀÇ Á¦¾à»ê¾÷ Á¤º¸±³·ù ¹× »óÈ£ °øµ¿¹ßÀü ¹æ¾ÈÀ» ¸ð»öÇϱâ À§ÇÑ MOU¸¦ ü°áÇÑ ¹Ù ÀÖÀ¸¸ç, Á¦1ȸ ÇÑ-Áß Á¦¾àÇùȸ °øµ¿¼¼¹Ì³ª´Â 2011³â 9¿ù Áß±¹ »óÇØ¿¡¼ °³ÃÖµÈ ¹Ù ÀÖ´Ù.